British scientists have announced that they have discovered three new genes which are connected to the most known form of breast cancer. The discovery is considered to be of utmost importance as the possible treatment will not in any way interact with other drugs such as tamoxifen.
More than 37, 000 women in the United Kingdom are diagnosed with hormonal breast cancer every year. 20 per cent of all the cases are caused by breast tumors.
Doctor Anita Dunbier, who represented the Breakthrough Breast Cancer Research Centre at The Institute of Cancer Research (ICR) in London, believes that this discovery could lead to really optimistic results which will come from future treatments. She said: “This is a surprising discovery. We found these genes in a place we thought we knew a lot about…it is like finding gold in Trafalgar Square. We now have to look further at how these genes work, but the discovery could lead to possible new therapies that will benefit women with breast cancer in the future.”
The doctor’s comparison suggests just how sudden was the discovery; all three genes were located right near the estrogen receptor gene, which is what triggers the hormonal breast cancer. It was studied by scientists for a very long time and is what science knows most about the human genome.
All three genes were marked as C6ORF97, C6ORF96 and C6ORF211. The latter was particularly related to tumors, while the first acted as a clear source of information of whether or not the tumor is returning. C6ORF96 is the least studied so far but scientists already have their hopes up about what information it may display as well.
Prof. Mitch Dowsett, the head of the research team at ICR is adamant about the possibilities concerning the discovery of these three genes. He said:
This research is exciting because it shows that while the estrogen receptor is the main driver of hormonal breast cancer, there are others next door to it that also appears to influence breast cancer behavior. We now need to better understand how they work together and how we can utilize them to save lives of women with breast cancer.
Breast cancer rates are continuing to go down as a study revealed it already went down by 2 percent from 1998 to 2007. There is still the need for earlier methods of detecting cancer as well as better treatments.